Clinical Trial: Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis: A Real-World Cohort Study

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935408) titled 'Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis: A Real-World Cohort Study' on Nov. 02.

Brief Summary: This study aims to evaluate whether long-term dual antiplatelet therapy (DAPT) with cilostazol is associated with a lower risk of recurrent symptomatic ischemic stroke or all-cause mortality compared with single antiplatelet therapy (SAPT) in patients with symptomatic moderate-to-severe intracranial arterial stenosis following the completion of standard DAPT.

Study Start Date: March 01

Study Type: OBSERVATIONAL

Condition: Ischemic Stroke Symptomatic Intracranial A...